129 related articles for article (PubMed ID: 8245526)
21. Modulation of the immune response to Mycobacterium tuberculosis during malaria/M. tuberculosis co-infection.
Chukwuanukwu RC; Onyenekwe CC; Martinez-Pomares L; Flynn R; Singh S; Amilo GI; Agbakoba NR; Okoye JO
Clin Exp Immunol; 2017 Feb; 187(2):259-268. PubMed ID: 27577087
[TBL] [Abstract][Full Text] [Related]
22. [The detection of antibodies to Mycobacterium tuberculosis and its reactivity to three different purified protein derivative by ELISA].
Zhang CW
Zhonghua Jie He He Hu Xi Za Zhi; 1991 Dec; 14(6):325-7, 375. PubMed ID: 1818772
[TBL] [Abstract][Full Text] [Related]
23. Protection from Mycobacterium avium complex disease in human immunodeficiency virus-infected persons with a history of tuberculosis.
Horsburgh CR; Hanson DL; Jones JL; Thompson SE
J Infect Dis; 1996 Dec; 174(6):1212-7. PubMed ID: 8940211
[TBL] [Abstract][Full Text] [Related]
24. Risk of reactivation of tuberculosis in the course of human immunodeficiency virus infection.
Di Perri G; Micciolo R; Vento S; Cruciani M; Marocco S; Carlotto A; Adami T; Mazzi R; Cazzadori A; Concia E
Eur J Med; 1993 May; 2(5):264-8. PubMed ID: 7902760
[TBL] [Abstract][Full Text] [Related]
25. Anergy skin testing and tuberculosis [corrected] preventive therapy for HIV-infected persons: revised recommendations. Centers for Disease Control and Prevention.
MMWR Recomm Rep; 1997 Sep; 46(RR-15):1-10. PubMed ID: 9332982
[TBL] [Abstract][Full Text] [Related]
26. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection.
Selwyn PA; Hartel D; Lewis VA; Schoenbaum EE; Vermund SH; Klein RS; Walker AT; Friedland GH
N Engl J Med; 1989 Mar; 320(9):545-50. PubMed ID: 2915665
[TBL] [Abstract][Full Text] [Related]
27. Surrogate marker of preclinical tuberculosis in human immunodeficiency virus infection: antibodies to an 88-kDa secreted antigen of Mycobacterium tuberculosis.
Laal S; Samanich KM; Sonnenberg MG; Belisle JT; O'Leary J; Simberkoff MS; Zolla-Pazner S
J Infect Dis; 1997 Jul; 176(1):133-43. PubMed ID: 9207359
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for increased immune reconstitution in response to Mycobacterium tuberculosis antigens in tuberculosis HIV-infected, antiretroviral-naïve patients.
da Silva TP; Giacoia-Gripp CBW; Schmaltz CA; Sant'Anna FM; Saad MH; Matos JA; de Lima E Silva JCA; Rolla VC; Morgado MG
BMC Infect Dis; 2017 Sep; 17(1):606. PubMed ID: 28874142
[TBL] [Abstract][Full Text] [Related]
29. Antibody markers of incident tuberculosis among HIV-infected adults in the USA: a historical prospective study.
Gennaro ML; Affouf M; Kanaujia GV; Brusasca PN; Mangura B; Reichman L
Int J Tuberc Lung Dis; 2007 Jun; 11(6):624-31. PubMed ID: 17519093
[TBL] [Abstract][Full Text] [Related]
30. B-cell immune responses in HIV positive and HIV negative patients with tuberculosis evaluated with an ELISA using a glycolipid antigen.
Simonney N; Chavanet P; Perronne C; Leportier M; Revol F; Herrmann JL; Lagrange PH
Tuberculosis (Edinb); 2007 Mar; 87(2):109-22. PubMed ID: 17030018
[TBL] [Abstract][Full Text] [Related]
31. [Role of BCG-depleted immunodominant antigens derived from M. tuberculosis in serological test for tuberculosis].
Zheng XF; Yi L; Wei PJ; Jia HY; Li HW; Zhao YL; Zhang HT
Zhonghua Yi Xue Za Zhi; 2011 Dec; 91(48):3405-8. PubMed ID: 22333252
[TBL] [Abstract][Full Text] [Related]
32. Rapid, early and specific diagnosis of tuberculosis and other mycobacterial diseases in Burundi.
Barihuta T; Rigouts L; Barette M; Collart JP; De Bruyn J; Kadende P; Kamamfu G; Douglas JT; Portaels F
Ann Soc Belg Med Trop; 1993; 73 Suppl 1():41-51. PubMed ID: 8129478
[TBL] [Abstract][Full Text] [Related]
33. Response to region of difference 1 (RD1) epitopes in human immunodeficiency virus (HIV)-infected individuals enrolled with suspected active tuberculosis: a pilot study.
Vincenti D; Carrara S; Butera O; Bizzoni F; Casetti R; Girardi E; Goletti D
Clin Exp Immunol; 2007 Oct; 150(1):91-8. PubMed ID: 17680823
[TBL] [Abstract][Full Text] [Related]
34. [IgG against A60 antigen and the tuberculin test in healthy individuals and tubercular patients].
Saz JV; Ladrón de Guevara MC
Enferm Infecc Microbiol Clin; 1992 Oct; 10(8):477-80. PubMed ID: 1489777
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users.
Graham NM; Nelson KE; Solomon L; Bonds M; Rizzo RT; Scavotto J; Astemborski J; Vlahov D
JAMA; 1992 Jan; 267(3):369-73. PubMed ID: 1727959
[TBL] [Abstract][Full Text] [Related]
36. Serodiagnostic potentialities of enzyme-linked immunosorbent assay (ELISA) using mannophosphoinositides of Mycobacterium tuberculosis H37Rv.
Mehta PK; Khuller GK
Med Microbiol Immunol; 1988; 177(5):285-92. PubMed ID: 2845238
[TBL] [Abstract][Full Text] [Related]
37. Cell-mediated immune response to tuberculosis antigens: comparison of skin testing and measurement of in vitro gamma interferon production in whole-blood culture.
Katial RK; Hershey J; Purohit-Seth T; Belisle JT; Brennan PJ; Spencer JS; Engler RJ
Clin Diagn Lab Immunol; 2001 Mar; 8(2):339-45. PubMed ID: 11238218
[TBL] [Abstract][Full Text] [Related]
38. Antigen-specific and persistent tuberculin anergy in a cohort of pulmonary tuberculosis patients from rural Cambodia.
Delgado JC; Tsai EY; Thim S; Baena A; Boussiotis VA; Reynes JM; Sath S; Grosjean P; Yunis EJ; Goldfeld AE
Proc Natl Acad Sci U S A; 2002 May; 99(11):7576-81. PubMed ID: 12032325
[TBL] [Abstract][Full Text] [Related]
39. Profiling serum antibodies to Mycobacterium tuberculosis proteins in rhesus monkeys with nontuberculous Mycobacteria.
Min F; Pan J; Wu R; Chen M; Kuang H; Zhao W
Exp Anim; 2016; 65(1):11-6. PubMed ID: 26437786
[TBL] [Abstract][Full Text] [Related]
40. Purified protein derivative (PPD)-tuberculin anergy and HIV infection: guidelines for anergy testing and management of anergic persons at risk of tuberculosis.
MMWR Recomm Rep; 1991 Apr; 40(RR-5):27-32. PubMed ID: 2034206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
